(NTNX) Nutanix - Overview
Sector: Technology | Industry: Software - Infrastructure | Exchange: NASDAQ (USA) | Market Cap: 12.138m USD | Total Return: -40.4% in 12m
Avg Turnover: 150M
EPS Trend: 66.7%
Qual. Beats: 1
Rev. Trend: 99.8%
Qual. Beats: 1
Warnings
Altman Z'' -3.71 < 1.0 - financial distress zone
Tailwinds
No distinct edge detected
Nutanix, Inc. is a global provider of enterprise cloud software specializing in hyperconverged infrastructure (HCI). Its core product, the Nutanix Cloud Platform, enables organizations to manage hybrid multicloud environments by integrating compute, virtualization, storage, networking, and security into a single software-defined solution. The company’s portfolio includes the AHV hypervisor, software-defined storage systems (Files, Objects, and Volumes), and specialized tools for Kubernetes management and artificial intelligence inferencing.
The business operates on a subscription-based model, transitioning from legacy hardware-bundled sales to a software-centric recurring revenue stream. In the broader IT infrastructure sector, HCI is a critical technology for data center modernization, as it replaces traditional three-tier architectures with a more scalable, unified stack. Nutanix serves a diverse range of industries including financial services, healthcare, and the public sector, often through strategic alliances with hardware and data infrastructure partners.
Investors can evaluate the company’s long-term valuation metrics and growth drivers on ValueRay. Nutanix continues to expand its addressable market by integrating cloud-native services and cyber resilience features into its unified control plane, Nutanix Prism.
- Broadcom acquisition of VMware accelerates enterprise migration to Nutanix cloud platform
- Subscription revenue growth and high renewal rates drive consistent free cash flow
- Strategic partnership with Dell expands distribution channels for hyperconverged infrastructure software
- Enterprise AI adoption fuels demand for GPT-in-a-Box and hybrid cloud storage
- Shift toward software-only model improves gross margins despite hardware supply chain volatility
| Net Income: 267.1m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.19 > 0.02 and ΔFCF/TA 9.96 > 1.0 |
| NWC/Revenue: 36.33% < 20% (prev 37.29%; Δ -0.97% < -1%) |
| CFO/TA 0.25 > 3% & CFO 832.2m > Net Income 267.1m |
| Net Debt (1.03b) to EBITDA (337.2m): 3.05 < 3 |
| Current Ratio: 1.65 > 1.5 & < 3 |
| Outstanding Shares: last quarter (294.2m) vs 12m ago 0.29% < -2% |
| Gross Margin: 87.14% > 18% (prev 0.86%; Δ 8.63k% > 0.5%) |
| Asset Turnover: 85.72% > 50% (prev 77.56%; Δ 8.16% > 0%) |
| Interest Coverage Ratio: 12.57 > 6 (EBITDA TTM 337.2m / Interest Expense TTM 21.0m) |
| A: 0.30 (Total Current Assets 2.47b - Total Current Liabilities 1.49b) / Total Assets 3.28b |
| B: -1.52 (Retained Earnings -4.99b / Total Assets 3.28b) |
| C: 0.08 (EBIT TTM 264.5m / Avg Total Assets 3.13b) |
| D: -1.21 (Book Value of Equity -4.98b / Total Liabilities 4.11b) |
| Altman-Z'' = -3.71 = D |
| DSRI: 0.67 (Receivables 260.6m/335.5m, Revenue 2.69b/2.32b) |
| GMI: 0.98 (GM 87.14% / 85.82%) |
| AQI: 0.80 (AQ_t 0.15 / AQ_t-1 0.19) |
| SGI: 1.16 (Revenue 2.69b / 2.32b) |
| TATA: -0.17 (NI 267.1m - CFO 832.2m) / TA 3.28b) |
| Beneish M = -3.49 (Cap -4..+1) = AA |
As of May 25, 2026, the stock is trading at USD 47.12 with a total of 5,782,110 shares traded.
Over the past week, the price has changed by +1.68%,
over one month by +16.17%,
over three months by +24.46% and
over the past year by -40.35%.
Nutanix has received a consensus analysts rating of 4.35. Therefore, it is recommended to buy NTNX.
- StrongBuy: 8
- Buy: 7
- Hold: 2
- Sell: 0
- StrongSell: 0
| Analysts Target Price | 54.7 | 16% |
P/E Trailing = 48.9837
P/E Forward = 21.2766
P/S = 4.5197
P/B = 98.7438
P/EG = 1.0138
Revenue TTM = 2.69b USD
EBIT TTM = 264.5m USD
EBITDA TTM = 337.2m USD
Long Term Debt = 1.35b USD (from longTermDebt, last quarter)
Short Term Debt = 33.1m USD (from shortTermDebt, last quarter)
Debt = 1.74b USD (from shortLongTermDebtTotal, last quarter) + Leases 196.7m
Net Debt = 1.03b USD (calculated: Debt 1.74b - CCE 711.7m)
Enterprise Value = 13.2b USD (12.1b + Debt 1.74b - CCE 711.7m)
Interest Coverage Ratio = 12.57 (Ebit TTM 264.5m / Interest Expense TTM 21.0m)
EV/FCF = 20.75x (Enterprise Value 13.2b / FCF TTM 634.5m)
FCF Yield = 4.82% (FCF TTM 634.5m / Enterprise Value 13.2b)
FCF Margin = 23.62% (FCF TTM 634.5m / Revenue TTM 2.69b)
Net Margin = 9.95% (Net Income TTM 267.1m / Revenue TTM 2.69b)
Gross Margin = 87.14% ((Revenue TTM 2.69b - Cost of Revenue TTM 345.5m) / Revenue TTM)
Gross Margin QoQ = 87.39% (prev 86.96%)
Tobins Q-Ratio = 4.02 (Enterprise Value 13.2b / Total Assets 3.28b)
Interest Expense / Debt = 1.21% (Interest Expense 21.0m / Debt 1.74b)
Taxrate = 11.00% (23.3m / 211.6m)
NOPAT = 235.4m (EBIT 264.5m * (1 - 11.00%))
Current Ratio = 1.55 (Total Current Assets 2.47b / Total Current Liabilities 1.59b)
Debt / Equity = -2.09 (negative equity) (Debt 1.74b / totalStockholderEquity, last quarter -831.3m)
Debt / EBITDA = 3.05 (Net Debt 1.03b / EBITDA 337.2m)
Debt / FCF = 1.62 (Net Debt 1.03b / FCF TTM 634.5m)
Total Stockholder Equity = -726.5m (last 4 quarters mean from totalStockholderEquity)
RoA = 8.53% (Net Income 267.1m / Total Assets 3.28b)
RoE = 6.27% (Net Income TTM 267.1m / Total Stockholder Equity 4.26b)
RoCE = 4.72% (EBIT 264.5m / Capital Employed (Equity 4.26b + L.T.Debt 1.35b))
RoIC = 12.96% (NOPAT 235.4m / Invested Capital 1.82b)
WACC = 8.32% (E(12.1b)/V(13.9b) * Re(9.36%) + D(1.74b)/V(13.9b) * Rd(1.21%) * (1-Tc(0.11)))
Discount Rate = 9.36% (= CAPM, Blume Beta Adj.)
Shares (quarterly) Correlation: 42.22 | Cagr: 9.17%
[DCF] Terminal Value 77.97% ; FCFF base≈493.1m ; Y1≈565.2m ; Y5≈831.9m
[DCF] Fair Price = 42.66 (EV 12.5b - Net Debt 1.03b = Equity 11.5b / Shares 269.3m; r=8.35% [WACC [floored]]; 5y FCF grow 15.0% → 2.50% )
EPS Correlation: 66.74 | EPS CAGR: 42.71% | SUE: 2.15 | # QB: 1
Revenue Correlation: 99.80 | Revenue CAGR: 16.46% | SUE: 1.82 | # QB: 1
EPS current Year (2026-07-31): EPS=1.82 | Chg30d=-0.23% | Revisions=+0% | GrowthEPS=+12.6% | GrowthRev=+11.2%
EPS next Year (2027-07-31): EPS=2.15 | Chg30d=-0.66% | Revisions=-14% | GrowthEPS=+17.6% | GrowthRev=+13.2%
[Analyst] Revisions Ratio: -14%